DURECT Announces Second Quarter 2017 Financial Results And Provides Corporate Update

Published: Aug 09, 2017

CUPERTINO, Calif., Aug. 8, 2017 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2017 and provided a corporate update.

Executed a U.S. commercialization agreement with Sandoz for POSIMIRĀ®, including a $20 million upfront payment, as well as milestone payments and double digit royalties.

Total revenues were $4.3 million and net loss was $9.9 million for the three months ended June 30, 2017 as compared to total revenues of $3.2 million and net loss of $9.0 million for the three months ended June 30, 2016.

Back to news